Some studies have suggested that LINC00582 is upregulated in multiple myeloma and acts as an oncogene by regulating the expression of genes such as SMO, IL6, and MYC through chromatin looping or microRNA sponging [50]. This evidence concerns the gene LINC00582 and plasma cell myeloma.